Screening for haemoglobinopathies

Current Paediatrics

Volumn 15, Issue 1, 2005, Pages 32-39

  Streetly, Allison ^a   Dick, Moira ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antenatal screening; Haemoglobinopathies; Newborn screening; Sickle cell disease

Indexed keywords

ACCURACY; CONGENITAL HYPOTHYROIDISM; FOLLOW UP; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HEMOGLOBINOPATHY; HUMAN; LABORATORY; MEDICAL AUDIT; MEDICAL SPECIALIST; MEDICAL STAFF; METHODOLOGY; MIDWIFE; NATIONAL HEALTH SERVICE; NEWBORN SCREENING; PATIENT CARE; PATIENT COUNSELING; PEDIATRICIAN; PHENYLKETONURIA; POPULATION; PRENATAL SCREENING; PRIMARY MEDICAL CARE; PUBLIC HEALTH; QUALITY CONTROL; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA; TRAINING; UNITED KINGDOM;

EID: 11844304325     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2004.10.005     Document Type: Article

References (13)

1. UK Department of Health Report of a Working Party of the Standing Medical Advisory Committee (SMAC) on Sickle Cell, Thalassaemia, and other haemoglobinopathies, HMSO, London, 1993.
2. G.R. Serjeant The role of preventive medicine in sickle cell disease. The Watson Smith Lecture J R Coll Phys Lon 30 1996 37 41
3. Consensus Development Conference Newborn screening for sickle cell disease and other hemoglobinopathies J Am Math Assoc 258 1987 1205 1209
4. H. Davies, P.J. Gergen, and Rm. Moore Geographic difference in mortality of young children with sickle cell disease in the USA Public Health Rep 112 1997 52 58
5. Olney, R., Newborn Screening for sickle cell disease in Genetics and Public Health in the 21st Century. Accessed at http://www.cdc.gov/genetics/ books/21stcent4a.htm
6. CDCP Mortality in children with sickle cell disease identified by newborn screening during 1990-1994 in California, Illinois & New York MMWR 47 1998 169 172
7. Davies SC, Cronin M, Greengross G, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research, vol. 4, No. 3, Health Technology Assessment, 2000 (http://www.hta. nhsweb.nhs.uk/execsumm/summ403.htm).
8. D. Zeuner, A. Ades, J. Karnon, J. Brown, C. Dezateux, and E. Anionwu Antenatal and neonatal haemoglobinopathy screening in the UK review and economic analysis Health Technol Assess 3 11 1999
9. AAP Newborn Screening Task Force Screening the family from birth to the medical home. Newborn screening a blueprint for the future Pediatrics 106 Suppl 2000 383 427
10. F. Sassi, L. Archard, and Le. Grand J. Equity and the economic evaluation of healthcare Health Technol Assess 5 3 2001
11. F. Sassi, L. Grand, and L. Archard Equity vs. efficiency a dilemma for the NHS Br Med J 323 2001 762 763
12. US Department of Health & Human Services: Sickle cell disease screening diagnosis and management and counselling in newborns ad infants. Rockville MD: Agency for Health Care and Policy Research, Public Health Service, 1993.
13. M.S. Harris, and J.R. Eckman Georgia's experience with newborn screening 1981-1985 Pediatrics 83 Suppl 1989 858 860